US Patent No: 8,048,449

Number of patents in Portfolio can not be more than 2000

Mouth dissolving pharmaceutical composition and process for preparing the same

Stats

ALSO PUBLISHED AS: 20080317853
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Disclosed herein is a orally disintegrating and/or dissolving oral pharmaceutical composition, comprising one or more active pharmaceutical ingredients, one or more fillers having particle size of 100 microns or above, a high and desirable amount of silicon dioxide, one or more disintegrating agents, optionally effervescent couple, wherein said composition has good organoleptic properties like desired mouth feel and fast oral disintegration time.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
JUBILANT ORGANOSYS LIMITEDNOIDA21

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kashid, Namdev Maharashtra, IN 4 2
Mukherji, Gour Gurgaon, IN 16 12

Cited Art

Patent Info (Count) # Cites Year
 
R.P. SCHERER CORPORATION (4)
5,188,825 Freeze-dried dosage forms and methods for preparing the same 43 1989
5,631,023 Method for making freeze dried drug dosage forms 46 1995
5,827,541 Process for preparing solid pharmaceutical dosage forms of hydrophobic substances 25 1996
5,976,577 Process for preparing fast dispersing solid oral dosage form 19 1997
 
CIMA LABS INC. (3)
5,178,878 Effervescent dosage form with microparticles 148 1992
6,024,981 Rapidly dissolving robust dosage form 54 1998
6,221,392 Rapidly dissolving robust dosage form 20 1999
 
ELAN PHARMA INTERNATIONAL LIMITED (1)
2003/0215,502 Fast dissolving dosage forms having reduced friability 10 2003
 
ETHYPHARM (1)
2004/0171,669 Coated granules based on angiotensin-converting enzyme inhibitor 2 2003
 
HANMI PHARM. CO., LTD. (1)
2002/0001,617 Rapidly disintegrating tablet and process for the manufacture thereof 8 2001
 
J.M. HUBER CORPORATION (1)
2005/0244,343 Oral care products comprising silica 1 2004
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
6,740,339 Quickly disintegrating solid preparations 3 2001
 
YUHAN CORPORATION (1)
2002/0071,864 Rapidly disintegrable tablet for oral administration 12 2001
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
2003/0175,339 Process for preparing a soft tablet 1 2003

Patent Citation Ranking

Forward Cites

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 1, 2015
7.5 Year Payment $3600.00 $1800.00 $900.00 May 1, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 1, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00